Newron Pharmaceuticals S.p.A. NWPHF
20.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
9.36 Day range 9.36
9.36 52-week range 20.00
- YTD
- +113.68%
- 1 year
- +113.68%
- Market cap
- 408.95M
- EPS (ttm)
- -0.74
- YTD return
- +113.68%
- 1-year return
- +113.68%
- Volume
- 986
- Open
- 9.36
- Previous close
- 20.00
- Day's range
- 9.36 – 9.36
- 52-week range
- 9.36 – 20.00
2Y +10.64 (+113.68%)
News
Newron Pharmaceuticals S.p.A. (NWPHF) Discusses FDA Clinical Hold and Safety Concerns in ENIGMA-TRS Program for Treatment-Resistant Schizophrenia Transcript 
Newron Pharmaceuticals to Participate in June Investor Conferences 
Newron Pharmaceuticals S.p.A. (NWPHF) Q4 2025 Earnings Call Transcript 
Newron Presents 2025 Financial Results and Provides 2026 Outlook 
Newron to Present at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS) 
Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia 
Short Interest in Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) Decreases By 23.0% 
EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan 
Newron to Host Investor and Partnering Meetings During the J.P. Morgan Healthcare Conference Week 
Newron presents H1 2025 results and provides business update
Your note
Sign in to keep a note on NWPHF — it syncs with the Stock Master app.